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Age-Dependent Alterations in Intestinal Wnt Signaling 
Revealed by Deletion of SFRP1  
Briana Leung, Kelly Gregory, Jennifer Ser-Dolansky, Salih Toker, Sallie Schneider 
BACKGROUND 
Familial adenomatous polyposis disease (FAP) is a genetic 
disorder characterized by the early development of hundreds to 
thousands of adenomatous polyps throughout the colon. Left 
untreated, 100% of patients will inevitably develop colon cancer 
by age 40 and thus, surgical intervention with total abdominal 
colectomy or total proctocolectomy is ultimately required. The 
multi-stage progression from early adenoma to adenocarcinoma 
involves an initiating mutation in the APC gene, a negative 
regulator of the Wnt pathway. 
 
 Secreted frizzled related proteins 
 (SFRPs) are typically thought of as antagonists which 
competitively binds to Wnt proteins, inhibiting the Wnt pathway 
and suppressing cancer. mRNA expression of SFRP1 is higher  
histologically normal mucosal areas relative to adjacent areas of 
colorectal  carcinoma. rSFRP1 has been shown to induce 
apoptosis in human colorectal cells in vitro and  
suppress growth of human SQ colorectal cancer xenografts in 
mice.  Aberration in the Wnt pathway is known to affect the 
proper development of stem cells (ISCs), Paneth and secretory 
goblet cells. 
 
In this study we sought to confirm 
the notion of SFRP1 as an  
antagonist of the Wnt pathway in the 
small and large intestine, but 
interestingly found a pubertal 
role for SFRP1 in maintaining 
Wnt machinery expression, as well  
as AP4 and stem cell marker  
expression. 
 
 
 
               
• SFRP1+/+ and SFRP1-/- mice were sacrificed at 5 weeks 
and 10-20 weeks of age (adults) 
• After excision of intestinal tissue, the colon and small 
intestine (further divided into duodenum, jejunum and 
ileum) were flushed with ice-cold PBS to remove stool 
• Tissues were fixed in formalin and embedded for H&E and 
PAS staining 
• Tissue RNA was isolated and RT-PCR performed for Wnt 
pathway genes and Ap4 
 
OBJECTIVE 
METHODS RESULTS 
CONCLUSIONS 
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• To examine the role of SFRP1 in intestinal gene 
expression and development. 
 
RESULTS 
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Figure 1. Gene expression of Wnt targets in 5wk old SFRP1-/- mouse intestine compared to adult SFRP1-/- mouse intestine  
Wnt1 Wnt3a Wnt5a Fzd5 
Figure 4. a PAS staining of colonic crypts in 5wk old WT vs. SFRP1-/- mice. b  Left: PAS staining of small intestinal villi in adult 
mouse. Right: quantification of PAS-positive cells in jejunal villi adult mouse (20 villi) 
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Figure 2.  Gene expression of Wnt proteins and Fzd5 receptor in in 5wk old SFRP1-/- versus  adult SFRP1-/- mouse intestine 
(jejunum)  
• SFRP1 deficiency in adult animals resulted in increased target gene 
expression consistent with its role as an antagonist. 
• Surprisingly, SFRP1 deficiency in pubertal mice was associated with a 
pattern of decreased Wnt pathway activation. 
• The decrease in Wnt target gene expression in pubertal SFRP1 
deficient animals was associated with decreased Wnt ligands and 
receptors suggesting an overall regulation of this receptor machinery.  
• Ap4, a transcription factor known to regulate Wnt ligands/receptors, 
was significantly downregulated in the pubertal SFRP1-deficient 
animals suggesting a possible mechanism for the difference. 
• An age-dependent change in Wnt activity uncovered by SFRP1 
deficiency was confirmed by examining Wnt controlled development of  
intestinal goblet cells 
5wk Jejunum 
Developing organoid cultures for personalized medicine 
Jennifer R. Ser-Dolansky, MS1  , Salih Toker, MD 2 and Sallie S. Schneider, PhD1,3 
 
1Biospecimen Research and Molecular Analysis Facility, PVLSI, Springfield MA 01199  2 UMMS-Baystate,  Dept. of Pathology, Springfield, MA 01199; 3UMMS-Baystate, 
Department of Surgery, Springfield, MA 01199 
Abstract 
      There is great promise in personalized medicine for improving outcomes in 
cancer. However, genetic analyses are often slow and expensive and the 
combined effects of mutations on treatment responses may still be unknown. 
Thus, the development of new technologies that can test responses to a wide 
range of treatment is beneficial. Growth and treatment of cells in 2-dimensions 
have not yielded results that predict the in vivo responses. PDX animals, on 
the other hand, maintain the tumor heterogeneity and structure, but are time 
consuming and expensive. We are developing the technology of 3D 
organoid/spheroid culture. In this system the tumor is broken down into 
hundreds of small pieces and cultured in 3 dimensions in extracellular matrix 
allowing us to capture and propagate these genetic and phenotypic changes 
in the tumor organoids. Normal cell: cell interactions are noted and in the early 
passages of tumor pieces (spheroids) immune cells are also present allowing 
for examination of checkpoint blockade inhibitors.  
       In this work, we are showing growth of ovarian tumor and breast tumor, as 
well as normal tissue organoids/spheroids. We have developed immuno-
histochemical and cytological techniques to analyze the cell types present or 
the activity of particular proteins. Future research aims to establish a panel of 
organoids to assess responses to novel treatments and to benefit other 
researchers interested in developing new treatment options. 
Results Results 
Conclusions 
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Figure 1.Schematic diagram showing potential use of organoids in 
personalized medicine.  Hundreds of organoids or spheroids can be 
cultured and plated in a multi-well plate for evaluation of tumor 
responses. Genetic profiling can be coupled with it to study a wide 
range of biological questions. 
A 
Figure 2: Immunohistochemistry / immunocytochemistry on breast and 
ovarian organoids A. Paraffin embedded breast tumor organoid stained 
with p53 antibody. B. Ovarian organoid in Matrigel stained fluorescently 
with EpCAM antibody. 
Figure 2. Organoid growth in 3D culture. A) Organoids derived from a 
breast tumor. B) Breast organoids derived from a reduction 
mammoplasty sample . C) Serous ovarian carcinoma organoids. 
Figure 4. Immune cells can be detected in early passage spheroids 
Organoids were stained with antibodies to CD3 (T cells), CD45 
(immune cells) and CD68 (macrophages). 
• We are able to dissociate cells from both tumor and normal 
tissue and grow then in 3 dimension in extracellular matrix. 
• We have been able to culture both breast and ovarian 
organoids. 
• We have demonstrated several methods for staining cells 
which will allow us to demonstrate cellular heterogeneity,  as 
well as changes in protein expression.  
• Future studies will use these organoids to look at treatment 
responses or exposure risks. 
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Development of a panel of human mammary epithelial cell lines for analysis of genetic 
variation on exposures 
Stephanie M. Morin1,2, Jessica Nieves5, Amye Black2, Gat Rauner3, Giovanna M Crisi4, Jennifer Ser-Dolansky1, Kelly J. Gregory1, Sandra Haddad5, D. Joseph Jerry1,2, Sallie 
S. Schneider1,2,6 
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Abstract 
Many studies that investigate toxicological and transformative 
changes of chemicals on the breast in vitro use the same 3-5 
breast cell lines (i.e.MCF-7, MCF10A, MEC16, or 76N Tert 
cells). These lines have been useful in the study of various 
developmental and cancer pathways and have played an 
integral role in the development of treatment. What these lines 
are unable to provide is a diverse genetic background that 
allows for the study of interindividual variation between women. 
We have been able to isolate, and in some cases, conditionally 
immortalize more than 50 human mammary epithelial cell 
(HMEC) cell lines from different women enrolled in the Rays of 
Hope Breast Registry. We have been able to characterize these 
lines through a variety of different methods. We investigated the 
epithelial cell type, the mammosphere forming ability, as well as 
the differences in responsiveness to a variety of chemicals. 
Results Results 
Conclusions 
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We would like to thank Ms. Eva Browne and Amy Roberts and for their help on 
these experiments 
Cell Line KERATIN 14 KERATIN 5 VIMENTIN KERATIN 18 
MCF10A <1 <5 <1 <1 
76N Tert <1 <1 <1 <1 
ME16C <1 <5 <1 <1 
HME-CC <10 <10 <1 <1 
554 P6 >10 >10 <1 <1 
555 P16 >10 >10 <5 <1 
563 P20 >10 >10 <1 <1 
569 P8 >10 >10 <1 <1 
698 P14 >10 >10 <1 <1 
753 P12 <5 <5 <5 <1 
811 P4 >10 >10 <1 <1 
833 P4 <10 <10 <1 <1 
847 P1 <1 <1 <1 <1 
876 P6 >10 <5 <1 <1 
1082 P4 <5 <10 <1 <1 
1106 P2 <5 <5 <1 <1 
1111 P5 >10 >10 <1 <1 
Figure 1.Isolation and characterization of breast cells A. Fresh mammary tissue was minced and dissociated overnight 
mammary digestion media. The cell pellet was collected and further dissociated at which point cells were plated 24 hours in 
Mammocult media before being plated in T media specific for primary cell culture. At that point cells were then able to either be 
grown as described or plated for conditional immortalization on an irradiated NIH 3T3 murine feeder layer with the addition of 
ROCK inhibitor (Y-27632). B. Real-time qPCR characterization of established and primary HMEC lines to characterize between 
basal and luminal cell populations. KERATIN14 and KERATIN 5 are markers for the basal cell type; VIMENTIN is a marker for 
fibroblast-like cells; KERATIN 18 is a marker for the luminal cell type. 
A 
B 
Figure 2. Flow cytometry to confirm the epithelial nature of the cells A. Representative real-time PCR data of cell lines used for 
fluorescent characterization. B-F. FACS analysis of several of the primary cell lines. Cells were stained with an EpCam specific 
antibody and a CK14 specific antibody. EpCam was used as a marker for epithelial cells and CK14 was used to confirm the basal 
cell type. 
Figure 3. The panel displays variation in responses to chemicals, hormones and growth factors. Luciferase reporter assays 
were used to determine variation in response to various chemicals. Luciferase activity is shown normalized to Renilla 
transfection control. Activity is shown relative to experimental controls for each cell line. A. Stably and conditionally 
immortalized HMEC lines transfected with ESR1 expression plasmid and treated with control, 10nM E2, 30uM BP3, or 10uM PP 
media for 24 hours. ERE-luc luciferase activity was measured to observe variation in estrogen responsiveness. B. HMEC lines 
transfected with XRE-luc to measure differences in aryl hydrocarbon receptor in response to PCB 126. C.  HMEC lines transfected 
with Caga-luc to measure differences in TGF-β when cells are treated with the TGF-β ligand. D. HMEC lines transfected with 
Topflash and treated with WNT3A conditioned media. 
Figure 4. The conditionally reprogrammed cells retain the ability to form mammospheres Cells were cultured in ultra-low 
attachment 96-well plates for 7 days. A. Representative images of mammosphere formation in three HMEC lines (563, HME-CC, 
and 876) and examples of no mammosphere formation in three HMEC lines (76N TERT, MCF10A, 847). B. Extreme limiting 
dilution assays (ELDA) were performed to determine the number of MFC in each HMEC line. Only lines that had mammosphere 
in preliminary mammosphere forming assay were tested. Error bars represent 95% confidence interval. Scale bars indicate 
100uM. 
• We have established a panel of HMEC lines from women with 
associated demographic information to study interindividual 
variation. 
• Examination of potential epithelial subtypes in our cultures 
demonstrate that our culture method enriches for basal-like 
epithelial cells. 
• Some of our conditionally immortalized HMEC lines have 
mammosphere forming abilities in ultra-low attachment 
cultures. 
• These lines can be used to examine the contribution of 
genetic variation to differential responsiveness to a variety of 
chemicals (i.e. PCBs or endocrine disrupting chemicals) or 
growth factors (i.e. Wnt or TGF-β).  
 
The Art of Physical Examination: Alcohol Abuse Masking 
Progressive Supranuclear Palsy 
Queisi, Munther, MD Shami, Ali MD Hasan, Maryam MD 
University of Massachusetts Medical School-Baystate  
BACKGROUND 
Progressive supranuclear palsy (PSP) is an underdiagnosed 
neurodegenerative disease typically affecting adults in their 
middle and late ages. Those affected usually have a poor 
prognosis with an average life expectancy of 5.9 years. Physical 
examination is paramount for accurate diagnosis. Our case 
discusses PSP and the clinical features that may be masked by 
concomitant history of chronic alcohol abuse.   
This case highlights how a history of alcohol abuse may 
delay the diagnosis of  neurodegenerative diseases 
such as PSP due to overlapping features of cognitive 
impairment, eye movement disorders and cerebellar 
ataxia. However downward gaze palsy on examination 
and brain imaging findings can differentiate PSP from 
alcohol abuse. Unfortunately, there is no treatment of 
PSP as dopaminergic medications show only transient 
or limited relief in symptoms. 
Geriatrics was consulted once other infectious and 
metabolic causes were ruled out. A thorough physical 
exam revealed that patient had vertical downward gaze 
with history of “backward” falls. Follow up MRI showed 
marked atrophy of midbrain tegmentum which 
confirmed PSP. 
 
CASE PRESENTATION  
ANOTHER HEADING DISCUSSION 
RB is a 78-year-old male with a history of alcohol abuse, 
previous brain abscess status post craniotomy, traumatic 
subarachnoid and subdural hemorrhages, who was transferred 
from an outside hospital after multiple episodes of repeated 
falls at home and altered mental status with restlessness and 
agitation. 
  
On examination, RB was found to be confused along with 
bilateral upper extremity resting tremors, which was noted on 
previous admissions as well.  He had vertical gaze palsy and 
hypertonia in the upper limbs greater than the lower limbs. He 
also had cogwheel rigidity, masked facies, and a shuffling, 
bradykinetic gait.  
  
Lab work revealed hyponatremia of 130, a negative urine 
toxicology screen and undetectable levels of alcohol. Clinical 
Institute Withdrawal Assessment (CIWA) was 12 on admission. 
CT brain ruled out any underlying acute abnormalities.  
 
The patient had been admitted in the past for acute 
pancreatitis, repeated falls and brain injuries secondary to 
alcohol intoxication. Given his known history of alcohol abuse, 
he was treated for alcohol withdrawal with lorazepam without 
any improvement in mentation.  
  
 
CONCLUSION  
A lack of response to levodopa makes PSP a more likely 
diagnosis than Parkinson’s disease. PSP is usually diagnosed 
clinically, but can be supported by magnetic resonance imaging. 
This may demonstrate severe pigment depletion of the 
substantia nigra. Unfortunately, there is no treatment of PSP as 
dopaminergic replacement therapy is only transiently or mildly 
effective in relieving some symptoms.   
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The use of patient-derived breast tissue explants to study resident macrophage 
polarization and the effects of xenoestrogen exposure 
Kelly J. Gregory1,2, Jennifer Ser-Dolansky1, Sallie S. Schneider1,3,5 
Affiliations: 1Pioneer Valley Life Sciences Institute, Baystate Medical Center, Springfield, MA, USA, 01107; 2Biology Department, University of Massachusetts, Amherst, MA, USA, 
01003; 3Veterinary and Animal Sciences Department, University of Massachusetts, Amherst, MA, USA, 01003 
ABSTRACT 
Using immortalized human cell line models in vitro or in vivo has aided researchers in the 
understanding of how normal mammary epithelial cells respond to neighboring cell signals. 
Our laboratory is in charge of ongoing collections of breast tissue for the Biospecimen 
Resource and Molecular Analysis facility at Baystate Medical Center. The continuous 
access to fresh breast tissue has allowed us to employ an ex vivo mammary explant model 
system comprised of intact human mammary tissue which is termed patient derived 
explant (PDE). This glandular tissue contains all the cells that would normally be present in 
the breast. As such, our collection of PDEs allows us to investigate cellular responses to 
external stimuli in situ in cells that are all normal and have normal heterotypic interactions.  
Macrophages comprise a portion of immune cells that are phagocytic in nature and are 
present in almost all tissues. In the breast, macrophages play an important role in 
ductal/lobular development. Depending on the microenvironmental signal present, 
macrophages are polarized into two distinct phenotypes, classically activated M1 
macrophages (proinflammatory) or alternatively activated M2 macrophages (wound healing 
and/or anti-inflammatory). Here we demonstrate that that we can polarize tissue resident 
macrophages within normal breast PDEs towards M1 or M2 through the addition of IFNγ + 
LPS or IL-4 + IL-13 respectively. Elevated expression levels of M1 markers (HLA-DRA and 
CXCL10) or M2a markers (CD209 and CCL18) are observed in cytokine treated tissues. 
Our ex vivo culture system further reveals that a subset of the PDEs respond to M2 
polarizing cytokines through down regulation of E-cadherin and upregulation of Vimentin 
which is reminiscent of EMT changes observed in cancer cells or “active” stromal 
phenotypes.  Furthermore, these changes highlight a variation in inter-individual responses 
that could possibly contribute to differences in susceptibility to breast cancer.  We have 
continued these PDE studies and used this model system to examine the impact of 
environmental exposures on the mammary gland. In particular, we are focusing on a 
xenoestrogen, oxybenzone (BP3), which is the active ingredient found in sunscreen.  
Considering that estrogen has been shown to increase the production of M2 related 
cytokines, we sought to determine whether BP3 could affect macrophage polarization in 
PDEs.  We measured significant, yet varying responses to BP3 particularly in untreated 
and M2-cytokine treated PDEs.  However, it is of interest that BP3 had no effect on EMT 
related gene expression.  Taken together, the PDE model system is an outstanding 
preclinical model to study early tissue resident immune responses and effects on epithelial 
and stromal responses to stimuli found both endogenously in the breast as well as 
exogenously due to exposures.  
 
METHODS 
RESULTS RESULTS 
CONCLUSIONS 
• The resident macrophages found in normal breast tissue PDEs are capable of 
responding to polarizing cytokines  as evidenced by the expression of classic M1 and 
M2a markers and inter-individual variation is noted in the responses. 
 
• In a subset of women, M2a polarized macrophages alter gene expression consistent 
with EMT process.  This is the first study to show the effects of M2a macrophage 
polarization on EMT in NORMAL epithelial tissue. 
 
•  BP3 does not affect M1 macrophage polarization or EMT gene expression, but in 
some cases does elicit significant changes in M2a macrophage marker gene 
expression which could potentially alter breast cancer susceptibility.  
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Figure 1.  Schematic for human tissue explant exposures. Fresh human breast tissue dissected to isolate fibroglandular 
tissue enriched with epithelium was placed on Surgifoam gelatin sponges with 3 mL of medium [(phenol red free DMEM/F12 
buffered with Hepes and NaHCO3, 5 µg/mL human insulin, 1X antibiotic/antimycotic. The media was left untreated (M0) , 
treated with M1 polarizing cytokines (LPS + IFNγ) or treated with M2a polarizing cytokines (IL-4 + IL-13). Additionally, in 
parallel wells the media was supplemented with benzophenone-3 (BP3). Media was removed after 72 hr and the tissue was 
flash frozen and stored at -80°C until being processed for RNA isolation. 
Figure 2. Normal breast PDEs can be polarized towards M1 or M2 through the addition of IFNγ + LPS 
or IL-4 + IL-13. RNA was harvested from cytokine exposed PDEs and mRNA levels of  HLA-DRA and CXL10 
(M1 markers) or CD209 and CCL18 (M2a markers) were analyzed via real-time PCR. All real-time PCR 
results are from two separate experiments performed in triplicate and results were normalized to amplification 
of CD68 (macrophage marker).  Bars represent mean ± SEM and are expressed as fold change with respect 
to M0 PDEs. *p<0.05, **p<0.01, ***p<0.001  (significantly different from indicated data set using student’s t-
test). 
 
Figure 3.  Schematic of epithelial to mesencyhmal transition (EMT). EMT  is a process whereby 
epithelial cells lose polarity as well as cell-cell contacts and undergo a dramatic remodeling of the 
cytoskeleton resulting in a mesenchymal morphology. Image obtained from 
https://upload.wikimedia.org/wikipedia/commons/8/89/Epithelial-Mesenchymal_Transition.gif 
Figure 4. Epithelial cells in PDEs  exhibit a gene expression pattern associated with EMT when 
macrophages are polarized toward the M2a phenotype. RNA was harvested from IL-4 + IL-13 exposed PDEs 
and mRNA levels of  E-cadherin (CDH1) and Vimentin (VIM) were analyzed via real-time PCR. All real-time PCR 
results are from two separate experiments performed in triplicate and results were normalized to amplification of 
CK 18 (epithelial cell marker).  Bars represent mean ± SEM and are expressed as fold change with respect to M0 
PDEs. *p<0.05, ***p<0.001 (significantly different from indicated data set using student’s t-test). 
Figure 5. The xenoestrogen oxybenzone (BP3) alters the expression of M2a markers in both untreated PDEs and 
those treated with IL-4 +IL-13. RNA was harvested from control (M0) and cytokine exposed (M2a) PDEs treated with 
either vehicle (DMSO) or 30 μM BP3 and mRNA levels of CD209 and CCL18 (M2a markers) were analyzed via real-time 
PCR. All real-time PCR results are from two separate experiments performed in triplicate and results were normalized to 
amplification of CD68 (macrophage marker).  Bars represent mean ± SEM and are expressed as fold change with 
respect to DMSO treated M0 PDEs. *p<0.05, **p<0.01, ***p<0.001   (significantly different from indicated data set using 
student’s t-test). 
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